P. André

R. Écochard, P. André, C. Scholtès, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte

S. Agaugué, P. André, V. Lotteau, 2020 .

Oxidized Low-Density Lipoprotein Promotes Mature Dendritic Cell Transition from Differentiating Monocyte1

S. Agaugué, P. André, V. Lotteau, 2001, The Journal of Immunology.

Lipogenesis and innate immunity in hepatocellular carcinoma cells reprogrammed by an isoenzyme switch of hexokinases

P. Vidalain, A. Aublin-Gex, P. André, 2020 .

Structural compartmentalization of MHC class II signaling function.

P. André, J. Salamero, J. Davoust, 1993, Immunology today.

Secretory phospholipase A 2 induces dendritic cell maturation

S. Agaugué, P. André, V. Lotteau, 2009 .

Secretory phospholipase A2 induces dendritic cell maturation

S. Agaugué, P. André, V. Lotteau, 2004, European journal of immunology.

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

P. André, V. Lotteau, G. Paranhos-Baccala, 2002, Journal of Virology.

Farnesoid X receptor‐α is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo

P. André, V. Lotteau, F. Cosset, 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Reciprocal regulation of farnesoid X receptor α activity and hepatitis B virus replication in differentiated HepaRG cells and primary human hepatocytes

P. André, V. Lotteau, M. Porcherot, 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Prevalence, Risk Factors, and Impact of Donor‐Specific Alloantibodies After Adult Liver Transplantation

P. André, J. Dumortier, V. Hervieu, 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

1-Methyl-Tryptophan Can Interfere with TLR Signaling in Dendritic Cells Independently of IDO Activity1

S. Agaugué, P. André, V. Lotteau, 2006, The Journal of Immunology.

Human group X secreted phospholipase A2 induces dendritic cell maturation through lipoprotein-dependent and -independent mechanisms.

P. André, V. Lotteau, G. Lambeau, 2012, Atherosclerosis.

Generation and Comprehensive Analysis of an Inﬂuenza Virus Polymerase Cellular Interaction Network (cid:1) †§

P. Vidalain, L. Tafforeau, F. Pradezynski, 2011 .

Th1 Disabled Function in Response to TLR4 Stimulation of Monocyte-Derived DC from Patients Chronically-Infected by Hepatitis C Virus

S. Agaugué, P. André, V. Lotteau, 2008, PloS one.

Hepatitis C Lipo-Viro-Particle from Chronically Infected Patients Interferes with TLR4 Signaling in Dendritic Cell

S. Agaugué, P. André, V. Lotteau, 2007, PloS one.

Farnesoid X receptor targeting for hepatitis C: study protocol for a proof-of-concept trial.

R. Écochard, P. André, F. Gueyffier, 2012, Therapie.

Modulation of HLA-G Antigens Expression by Human Cytomegalovirus: Specific Induction in Activated Macrophages Harboring Human Cytomegalovirus Infection1

P. André, R. Fauchet, C. Pangault, 2000, The Journal of Immunology.

Selectivity of the major histocompatibility complex class II presentation pathway of cortical thymic epithelial cell lines

L. Karlsson, P. André, V. Lotteau, 1997, European journal of immunology.

HIV-1 Load Comparison Using Four Commercial Real-Time Assays

R. Écochard, P. André, B. Pozzetto, 2010, Journal of Clinical Microbiology.

Low‐level viremia is associated with non‐B subtypes in patients infected with HIV with virological success following HAART introduction

R. Écochard, P. André, C. Scholtès, 2013, Journal of medical virology.

Variants With Different Mutation Patterns Persist in the Quasispecies of Enfuvirtide-Resistant HIV-1 Population During and After Treatment In Vivo

P. André, L. Cotte, C. Trépo, 2007, Journal of acquired immune deficiency syndromes.

Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study

P. André, N. Kootstra, P. Tangkijvanich, 2021, Journal of viral hepatitis.

Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity.

X. de Lamballerie, P. André, J. Neyts, 2016, Journal of hepatology.

Running title: 1-MT can modify dendritic cell functions

S. Agaugué, P. André, Lotteau, 2008 .

Independently of IDO Activity TLR Signaling in Dendritic Cells 1-Methyl-Tryptophan Can Interfere with

S. Agaugué, P. André, V. Lotteau, 2006 .

Human Polycomb group EED protein negatively affects HIV-1 assembly and release

P. André, J. Darlix, P. Boulanger, 2007, Retrovirology.

Distinct structural compartmentalization of the signal transducing functions of major histocompatibility complex class II (Ia) molecules

P. André, J. Cambier, T. Wade, 1994, The Journal of experimental medicine.

Automated determination of amplified PCR products: application to HCV viremia detection and quantification.

P. André, R. Colimon, S. Minjolle, 1995, Cellular and molecular biology.

Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins.

P. André, V. Lotteau, F. Zoulim, 2006, The Journal of general virology.

Duplex High-Resolution Melting Assay for the Simultaneous Genotyping of IL28B rs12979860 and PNPLA3 rs738409 Polymorphisms in Chronic Hepatitis C Patients

P. André, A. Sin, C. Ramière, 2015, International journal of molecular sciences.

Infection Harboring Human Cytomegalovirus Induction in Activated Macrophages by Human Cytomegalovirus: Specific Modulation of HLA-G Antigens Expression

P. André, R. Fauchet, C. Pangault, 2000 .

Deleterious impact of C3d-binding donor-specific anti-HLA antibodies after pediatric liver transplantation.

P. André, J. Dumortier, V. Hervieu, 2017, Transplant immunology.

Morphological Characterization and Fusion Properties of Triglyceride-rich Lipoproteins Obtained from Cells Transduced with Hepatitis C Virus Glycoproteins*

P. André, O. Lambert, P. Bonnafous, 2010, The Journal of Biological Chemistry.

Standardized One-Step Real-Time Reverse Transcription-PCR Assay for Universal Detection and Quantification of Hepatitis Delta Virus from Clinical Samples in the Presence of a Heterologous Internal-Control RNA

P. André, F. Zoulim, C. Scholtès, 2012, Journal of Clinical Microbiology.

The metabolic sensors FXR (cid:1) , PGC-1 (cid:1) , and SIRT1 cooperatively regulate hepatitis B virus transcription

P. André, V. Lotteau, C. Scholtès, 2014 .

High plasma level of nucleocapsid‐free envelope glycoprotein‐positive lipoproteins in hepatitis C patients

P. André, V. Lotteau, R. Bartenschlager, 2012, Hepatology.

Structural Studies of Self-Assembled Subviral Particles: Combining Cell-Free Expression with 110 kHz MAS NMR Spectroscopy.

B. Meier, P. André, R. Bartenschlager, 2018, Angewandte Chemie.

Acute hepatitis C with evidence of heterosexual transmission: a new case.

P. André, J. Dumortier, C. Scholtès, 2014, Clinics and research in hepatology and gastroenterology.

A Bioluminescent 3CLPro Activity Assay to Monitor SARS-CoV-2 Replication and Identify Inhibitors

P. Vidalain, P. André, V. Lotteau, 2021, Viruses.

Transmission of low‐density hepatitis C viral particles during sexually transmitted acute resolving infection

P. André, V. Lotteau, J. Esteban, 2008, Journal of medical virology.

TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection

A. Aublin-Gex, P. André, V. Lotteau, 2017, Scientific Reports.

Assembly of infectious hepatitis C virus particles.

Ralf Bartenschlager, F. Penin, P. André, 2011, Trends in microbiology.

Activity of Hexokinase Is Increased by Its Interaction with Hepatitis C Virus Protein NS5A

P. André, V. Lotteau, J. Rodriguez, 2014, Journal of Virology.

Mature Dendritic Cell Generation Promoted by Lysophosphatidylcholine1

S. Agaugué, P. André, V. Lotteau, 2002, The Journal of Immunology.

Inhibitory Effects of Specific Apolipoprotein C-III Isoforms on the Binding of Triglyceride-rich Lipoproteins to the Lipolysis-stimulated Receptor*

P. André, V. Lotteau, C. Mann, 1997, The Journal of Biological Chemistry.

Clearance of serum HBsAg and anti‐HBs seroconversion following antiviral therapy for chronic hepatitis B

P. André, F. Zoulim, C. Trépo, 2009, Journal of medical virology.

Quantitation of HCV RNA using real-time PCR and fluorimetry.

P. André, V. Lotteau, P. Chevallier, 2001, Journal of virological methods.

Prediction of the virological response to etravirine in clinical practice: Comparison of three genotype algorithms

P. André, L. Cotte, C. Trépo, 2009, Journal of medical virology.

Strand specific quantitative real-time PCR to study replication of hepatitis C virus genome.

P. André, V. Lotteau, B. Deiman, 2004, Journal of virological methods.

Natural polymorphisms in HIV‐1 protease: Impact on effectiveness of a first‐line lopinavir‐containing antiretroviral therapy regimen

P. André, Y. Yazdanpanah, L. Cotte, 2008, Journal of medical virology.

A hexokinase isoenzyme switch in human liver cancer cells promotes lipogenesis and enhances innate immunity

P. Vidalain, A. Aublin-Gex, P. André, 2021, Communications Biology.

A hexokinase isoenzyme switch in human liver cancer cells promotes lipogenesis and enhances innate immunity

P. Vidalain, A. Aublin-Gex, P. André, 2021, Communications biology.

Virus-host interactomics: new insights and opportunities for antiviral drug discovery

B. de Chassey, P. André, V. Lotteau, 2014, Genome Medicine.

Effects of the proteasome inhibitor ritonavir on glioma growth in vitro and in vivo.

P. André, V. Lotteau, M. Peschanski, 2004, Molecular cancer therapeutics.

Structure homology and interaction redundancy for discovering virus–host protein interactions

Vincent Lotteau, Vincent Navratil, V. Navratil, 2013, EMBO reports.

Biochemical and Morphological Properties of Hepatitis C Virus Particles and Determination of Their Lipidome*

M. Hiet, P. André, R. Bartenschlager, 2010, The Journal of Biological Chemistry.

A case of Mayaro virus infection imported from French Guiana.

P. André, I. Leparc-Goffart, C. Ramière, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Measuring human immunodeficiency virus type 1 RNA loads in dried blood spot specimens using NucliSENS EasyQ HIV-1 v2.0.

Tom Oosterlaken, P. André, P. van Deursen, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR.

P. André, V. Lotteau, R. Bartenschlager, 2008, Journal of hepatology.

VirHostNet: a knowledge base for the management and the analysis of proteome-wide virus–host interaction networks

Christian Gautier, Vincent Lotteau, Chantal Rabourdin-Combe, 2008, Nucleic Acids Res..

HIV-1 Subtype distribution in morocco based on national sentinel surveillance data 2004-2005

P. André, M. Salemi, R. Cook, 2012, AIDS Research and Therapy.

The current landscape of coronavirus-host protein–protein interactions

P. Vidalain, P. André, V. Lotteau, 2020, Journal of Translational Medicine.

Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma

P. André, J. Pawlotsky, J. Izopet, 2017, PloS one.

Amplification and pyrosequencing of near-full-length hepatitis C virus for typing and monitoring antiviral resistant strains.

P. André, N. Tarbouriech, W. Burmeister, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Recent evidence of underestimated circulation of hepatitis C virus intergenotypic recombinant strain RF2k/1b in the Rhône-Alpes region, France, January to August 2014: implications for antiviral treatment.

P. André, F. Bailly, J. Nana, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients.

P. André, J. Pawlotsky, S. Bertrais, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

French National Sentinel Survey of Antiretroviral Drug Resistance in Patients With HIV-1 Primary Infection and in Antiretroviral-Naive Chronically Infected Patients in 2001-2002

F. Brun-Vézinet, P. André, B. Masquelier, 2005, Journal of acquired immune deficiency syndromes.

Failure and success of HIV tests for the prevention of HIV‐1 transmission by blood and tissue donations

P. André, V. Barlet, C. Guitton, 2004, Journal of medical virology.

HIV-1 sequences isolated from patients promote expression of shorter isoforms of the Gag polyprotein

P. André, Sylvain de Breyne, T. Ohlmann, 2016, Archives of Virology.

Secretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive Lipoproteins

F. Penin, P. André, V. Lotteau, 2009, PloS one.

Comparison of HIV‐1 drug‐resistance genotyping by ultra‐deep sequencing and sanger sequencing using clinical samples

P. André, C. Scholtès, C. Ramière, 2017, Journal of medical virology.

The Interactomes of Influenza Virus NS1 and NS2 Proteins Identify New Host Factors and Provide Insights for ADAR1 Playing a Supportive Role in Virus Replication

Ralf Bartenschlager, Vincent Lotteau, B. de Chassey, 2013, PLoS pathogens.

Toll-like Receptor 4–Induced Glycolytic Burst in Human Monocyte-Derived Dendritic Cells Results from p38-Dependent Stabilization of HIF-1α and Increased Hexokinase II Expression

A. Aublin-Gex, P. André, V. Lotteau, 2018, The Journal of Immunology.

Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patient.

P. André, L. Cotte, J. Saison, 2015, AIDS research and human retroviruses.

What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM

P. André, G. Carcelain, A. Samri, 2017, EBioMedicine.

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

R M Zinkernagel, P. Klenerman, R. Zinkernagel, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Modulation of HLA-G antigens expression in myelomonocytic cells.

P. André, B. Drénou, R. Fauchet, 2000, Human immunology.

Circulating RNA Molecules as Biomarkers in Liver Disease

P. André, A. Sin, C. Ramière, 2014, International journal of molecular sciences.

Mapping of Chikungunya Virus Interactions with Host Proteins Identified nsP2 as a Highly Connected Viral Component

P. Vidalain, Y. Jacob, L. Tafforeau, 2012, Journal of Virology.

Highly Connected Viral Component with Host Proteins Identified nsP2 as a Mapping of Chikungunya Virus Interactions

P. Vidalain, Y. Jacob, L. Tafforeau, 2012 .

The current landscape of coronavirus-host protein–protein interactions

P. Vidalain, P. André, V. Lotteau, 2020, Journal of Translational Medicine.

New horizons for antiviral drug discovery from virus-host protein interaction networks.

Vincent Lotteau, B. de Chassey, A. Aublin-Gex, 2012, Current opinion in virology.

Genetic screens for the control of influenza virus replication: from meta-analysis to drug discovery.

B. de Chassey, A. Aublin-Gex, P. André, 2012, Molecular bioSystems.

Sensing Environmental Lipids by Dendritic Cell Modulates Its Function 1

S. Agaugué, P. André, V. Lotteau, 2004, The Journal of Immunology.

Different effects of the TAR structure on HIV-1 and HIV-2 genomic RNA translation

P. André, A. Cimarelli, Emiliano P. Ricci, 2011, Nucleic acids research.

Role of nuclear receptors in hepatitis B and C infections.

P. André, V. Lotteau, C. Scholtès, 2011, Clinics and research in hepatology and gastroenterology.

Domain 2 of Hepatitis C Virus Protein NS5A Activates Glucokinase and Induces Lipogenesis in Hepatocytes

P. Vidalain, A. Aublin-Gex, P. André, 2022, International journal of molecular sciences.

ViralORFeome: an integrated database to generate a versatile collection of viral ORFs

Christophe Combet, Gilbert Deléage, Christian Gautier, 2009, Nucleic Acids Res..

The metabolic sensors FXRα, PGC‐1 α, and SIRT1 cooperatively regulate hepatitis B virus transcription

P. André, V. Lotteau, C. Scholtès, 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Hepatitis C virus/human interactome identifies SMURF2 and the viral protease as critical elements for the control of TGF‐β signaling

P. André, V. Lotteau, M. Porcherot, 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Discordance in HIV‐1 Co‐receptor use prediction by different genotypic algorithms and phenotype assay: Intermediate profile in relation to concordant predictions

P. André, L. Cotte, C. Scholtès, 2012, Journal of medical virology.

Hepatitis C virus assembly: when fat makes it easier.

P. André, V. Lotteau, 2008, Journal of hepatology.

Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo.

P. André, V. Lotteau, J. Scoazec, 2004, The Journal of general virology.

Protection against experimental autoimmune encephalomyelitis by a proteasome modulator

P. André, V. Lotteau, M. Peschanski, 2001, Journal of Neuroimmunology.

Hepatitis E in liver transplant recipients in the Rhône-Alpes region in France

P. André, C. Scholtès, C. Ramière, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

In vitro studies reveal that different modes of initiation on HIV‐1 mRNA have different levels of requirement for eukaryotic initiation factor 4F

P. André, Sylvain de Breyne, T. Ohlmann, 2012, The FEBS journal.

Real-life evaluation of a human immunodeficiency virus screening algorithm using a single combined p24 antigen–antibody assay

P. André, C. Ramière, J. Tardy, 2013, European Journal of Clinical Microbiology & Infectious Diseases.

Farnesoid X receptor alpha ligands inhibit HDV in vitro replication and virion infectivity.

P. André, V. Lotteau, D. Durantel, 2023, Hepatology communications.

Hepatitis C as a metabolic disease

P. André, 2012, Retrovirology.

Triacylglycerol biosynthesis: another cellular lipid pathway essential to HCV replication

P. André, V. Lotteau, C. Scholtès, 2011 .

Sexually transmitted HCV infection and reinfection in HIV-infected homosexual men.

P. André, F. Zoulim, L. Cotte, 2009, Gastroenterologie clinique et biologique.

Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen

V. Calvez, C. Charpentier, P. André, 2018, The Journal of antimicrobial chemotherapy.